Effect of New Evidence on Antithrombotic Therapies in Atrial Fibrillation Patients Who Undergo Percutaneous Coronary Intervention in Alberta, Canada

Background: Trials have addressed the combined use of direct oral anticoagulants (DOACs) and antiplatelets in atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI). These trials may have changed prescribing patterns. Methods: This administrative audit of Albertans wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Theresa E. Eberhardt, PharmD, ACPR, Tammy J. Bungard, BSP, PharmD, Michelle M. Graham, MD, FRCPC, FCCS, Michelle Picard, BScPharm, ACPR, Grace T. Wang, MMath, Margaret L. Ackman, BScPharm, PharmD, ACPR, FCSHP
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2022-04-01
Col·lecció:CJC Open
Accés en línia:http://www.sciencedirect.com/science/article/pii/S2589790X21003565
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars